Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025)
Collegium Pharmaceutical (COLL) posted quarterly Other Non Operating Income of -$16.0 million for Q4 2025, down 285.86% quarter-over-quarter from -$4.1 million in Q3 2024.
Collegium Pharmaceutical (COLL) Other Non Operating Income (2014 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$16.0 million for Q4 2025.
- In Q4 2025, Other Non Operating Income changed N/A year-over-year to -$16.0 million; the TTM figure through Dec 2025 stood at -$16.0 million (down 41.18% YoY), while the FY2025 annual figure was -$16.0 million, down 41.18% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$16.0 million, down from -$4.1 million in the prior quarter.
- The five-year high for Other Non Operating Income was $23.5 million in Q1 2023, with the low at -$47.0 million in Q2 2023.
- The 3-year median for Other Non Operating Income is -$7.2 million (2024), against an average of -$10.2 million.
- Peak annual rise in Other Non Operating Income reached 84.72% in 2024, while the deepest fall reached 84.72% in 2024.
- Collegium Pharmaceutical's Other Non Operating Income stood at -$47.0 million in 2023, then surged by 91.18% to -$4.1 million in 2024, then sank by 285.86% to -$16.0 million in 2025.
- Business Quant data shows COLL's Other Non Operating Income at -$16.0 million in Q4 2025, -$4.1 million in Q3 2024, and -$7.2 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.99 Mn |
| Sep 30, 2024 | -4.15 Mn |
| Jun 30, 2024 | -7.18 Mn |
| Jun 30, 2023 | -47.01 Mn |
| Mar 31, 2023 | 23.50 Mn |
| Dec 31, 2017 | 180,000.00 |
| Sep 30, 2017 | 167,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Dec 31, 2016 | 20,000.00 |
| Sep 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -46,000.00 |
| Mar 31, 2016 | -66,000.00 |
| Dec 31, 2015 | -89,000.00 |
| Sep 30, 2015 | -97,000.00 |
| Jun 30, 2015 | -99,000.00 |
| Mar 31, 2015 | 91,000.00 |
| Dec 31, 2014 | -142,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Jun 30, 2014 | -29,000.00 |